You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lurbinectedin

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Los Angeles, California
    Sarcoma Oncology Center
Oct 16, 2023

Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)

Not yet recruiting
  • Ewing Sarcoma
  • +3 more
  • Lurbinectedin
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 27, 2023

Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • Lurbinectedin
  • (no location specified)
May 26, 2023

RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

Completed
  • Small-cell Lung Cancer
  • Lurbinectedin
  • Paris, France
  • +1 more
Jan 5, 2023

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • Lurbinectedin
  • (no location specified)
Feb 15, 2023

Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

Recruiting
  • Lung Cancer
  • Small-cell Lung Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Nov 9, 2022

Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small

Recruiting
  • Platinum-Resistant Lung Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Barcelona, Spain
  • +4 more
Aug 12, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Lurbinectedin
  • Stanford, California
  • +15 more
Dec 21, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,

Recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta (Lurbinectedin, Palliative Radiation

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Lurbinectedin
  • Palliative Radiation Therapy
  • Atlanta, Georgia
  • +2 more
Apr 12, 2022

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Carboplatin, Pemetrexed, Paclitaxel)

Recruiting
  • Lung Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 24, 2023

Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

Withdrawn
  • Metastatic Ewing Sarcoma
  • Recurrent Ewing Sarcoma
  • Fine-Needle Aspiration
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Advanced Solid Tumor, Hepatic Impairment Trial in Málaga, Barcelona, Madrid (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • Hepatic Impairment
  • Lurbinectedin
  • Málaga, Andalucía, Spain
  • +5 more
Oct 19, 2021

Advanced Solid Tumor Trial in Madrid (Lurbinectedin, Bosentan)

Recruiting
  • Advanced Solid Tumor
  • Madrid, Spain
  • +1 more
Sep 27, 2021

Malignant Pleural Mesothelioma, Advanced Trial in Italy, Switzerland (Lurbinectedin)

Completed
  • Malignant Pleural Mesothelioma, Advanced
  • Lurbinectedin
  • Alessandria, Italy
  • +7 more
Jul 13, 2021

Relapsed Small Cell Lung Cancer Trial in Worldwide (Irinotecan, Lurbinectedin, Topotecan)

Recruiting
  • Relapsed Small Cell Lung Cancer
  • Joliet, Illinois
  • +94 more
Aug 12, 2022

Small Cell Lung Cancer Trial (Lurbinectedin)

Approved for marketing
  • Small Cell Lung Cancer
  • Lurbinectedin
  • (no location specified)
Jun 17, 2020